Equasens Stock

Equasens FCF Yield

The Free Cash Flow Yield of Equasens (EQS.PA) as of Aug 11, 2026 is 8.58 %. In the previous year, Free Cash Flow Yield was 6.54 % — a change of 31.16% (higher).

FCF Yield

8.58 %

YoY

31.16%

Last updated:

Free Cash Flow Yield of Equasens is 2026 8.58 % . Free Cash Flow Yield of Equasens was 2025 6.54 % . It decreases by 31.16% higher compared to the previous year.
Access this data via the Eulerpool API

Equasens Stock analysis

What does Equasens do? Pharmagest Interactive SA is a leading provider of digital solutions for pharmacies and healthcare providers. The company was founded in France in 1986 and is headquartered in Villers-lès-Nancy. The company offers a wide range of software solutions for healthcare providers and pharmacies. Its main business areas include pharmacy management systems, healthcare management solutions, and telemedicine solutions. Pharmagest Interactive SA's pharmacy management systems include software solutions for inventory management, prescription management, and billing. The company also provides e-learning courses and training for pharmacies. Its healthcare management solutions focus on patient data management, with features such as patient records, appointment scheduling, and prescription management. These solutions are used by healthcare providers to optimize patient data management and improve patient care. Pharmagest Interactive SA also offers telemedicine solutions, including remote visit applications, online consultations, and teleconsultations. These solutions are particularly useful for patients in rural areas or with limited mobility. The company's products and services include Crossway, a pharmacy management software; LGPI, a patient management software for hospitals and healthcare providers; Noviatek, a digital prescription management system; and Monolog, a cloud-based platform for telemedicine services. In summary, Pharmagest Interactive SA provides a variety of digital solutions for pharmacies and healthcare providers, focusing on optimizing patient data management, inventory management, and billing. The company is also a pioneer in telemedicine solutions. Equasens is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Equasens stock

Free Cash Flow Yield of Equasens is 8.58 % in 2026.

Free Cash Flow Yield of Equasens changed from 6.54 % to 8.58 %, representing a 31.16% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow Yield Equasens since 2006 – with annual values, charts, and detailed analysis.

FCF Yield measures the free cash flow per share relative to the stock price. It indicates how much cash a company generates for each dollar invested.

To evaluate Free Cash Flow Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Yield.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Yield's Equasens with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Equasens

All Key Metrics — Equasens